−£207k
vs Apr 2024Active11922783Private limited companyBristol
INNERVATE THERAPEUTICS LTD
Significant control: Prof Steven Streatfield Gill (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Innervate Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Innervate Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
INNERVATE THERAPEUTICS LTD is an active private limited company (company number 11922783) incorporated on 3 April 2019, registered in Bristol. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 April 2025, showing net assets of −£207k and cash of £8,141, with 4 employees on average. Net assets fell 49% on the prior period (−£138k).
Peer position · net assets
By net assets it sits in the bottom quarter of 50 comparable companies in Bristol (median £17k, upper quartile £164k).
02
Ownership and control
- Prof Steven Streatfield Gill
- owns 50–75% of shares
- holds 50–75% of voting rights
- Xced Llp
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 3 April 20197 yrs ago
- Next accounts due
- 30 January 2027in 94 days
- Confirmation statement due
- 17 April 2027in 171 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£8,141
−93%vs Apr 2024Not reported
4
No changevs Apr 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | −£207k | £8,141 | £4,364 | — | — | — | 4 |
| 30 April 2024 | −£138k | £119k | £25k | — | — | — | 4 |
Cash per employee£2,035Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-206,719 at 30 April 2025
- Net assets down 25% or more on the prior period-49.3% vs prior period
- Incorporated five or more years agoIncorporated 3 April 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 171 days
- Next accounts duein 94 days
- Accounts period endNet liabilities £207k · small accounts
- Accounts period endNet liabilities £138k · small accounts
- Incorporated
08
Similar companies in Bristol
- XPAED LIMITEDBristol · inc. Aug 2019
- CBDERMA TECHNOLOGY LIMITEDBristol · inc. Aug 2019
- GENOMIC LABS LTDBristol · inc. Aug 2019
- BREW DAIRY LTDBath · inc. Sept 2019
- FERRYX LIMITEDStoke Gifford · inc. Sept 2019
- VIRTUS RESPIRATORY RESEARCH LIMITEDBristol · inc. Sept 2018
All companies incorporated on 3 April 2019 · in Apr 2019.
09
Reminders for INNERVATE THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.